Three-pronged platform—venture investing, Inflect Studio company-building, and Inflect Advisory consulting—validates solutions against live clinical workflows and leverages 8,000+ clinicians across 450+ locations. With a disciplined investment approach, the team drives value for both founders and investors.
Venture studio and fund that co‑incubates with LifePoint executives, giving startup ventures direct access to a $50B+ health system for pilot deployment, real‑world validation, and underserved population focus. Through targeted capital deployment, the fund plays an active role in the startup ecosystem.
30n operates as a venture fund geared toward investing in early-phase emerging ventures with a mission to create an equitable and sustainable future. They invest in a suite of industries, including technology, media, health care, and finance, and are driven to creating long-term value for their portfolio ventures. Their portfolio includes companies working on aI-powered technology, health tech, software, hardware, and more. Furthermore, fund also delivers resources to their portfolio ventures such as mentorship, network access, and strategic advice. 30n maintains a presence in San Francisco, New York, and London.
Acts as a VC and venture studio—co-founds emerging ventures with 25–30% of capital, assembles top‑1% specialists, and builds national‑capability defense, industrials, and bio‑infrastructure companies with corporate partners. The firm continues to build its presence across the venture capital landscape.
Leads mega-rounds for frontier-tech visions; delivers a 150+ person platform (recruiting, marketing, technical); doubles as a media company producing podcasts and research, and pursues aggressive crypto and illiquid-asset investments. With a disciplined investment approach, the team drives value for both founders and investors.
Partner-led, technology-over-ego firm that publicly distributes memos, quantified roadmaps and its anti-roster, and presents apprenticeship mentorship plus early AI/developer-framework foresight.
Specialized growth-equity investor in natural and organic CPG providing founders privileged deal flow and distribution insight via Presence Marketing ties and 70+ years of sector-specific operating and deal experience. The firm continues to build its presence across the venture capital landscape.
